Editorial: The tsunami of steatotic liver disease in India, the Asia-Pacific region and the world-Authors' reply.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford : Wiley-Blackwell
      Original Publication: [Oxford, OX] : Blackwell Scientific Publications, [c1987-
    • Subject Terms:
      Fatty Liver*; Humans ; Asia/epidemiology ; India/epidemiology
    • References:
      Shaheen A, Brahmania M. Editorial: The tsunami of steatotic liver disease in India, the Asia-Pacific region and the world. Aliment Pharmacol Ther. 2024;59:900-901.
      Prabhakar T, Prasad M, Kumar G, Kaushal K, Shenoy PS, Dubey S, et al. High prevalence of MAFLD in general population: a large cross-sectional study calls for concerted public health action. Aliment Pharmacol Ther. 2024;59:843-851.
      Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202-209.
      Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2023;20:101133.
      Rodrigues MH, Bruno AS, Nahas-Neto J, Santos ME, Nahas EA. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2014;30(5):325-329.
      Kumar R, Rastogi A, Sharma MK, Bhatia V, Garg H, Bihari C, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17(4):665-671.
      Prasad M, Sarin SK, Chauhan V. Expanding public health responses to non-communicable diseases: the NAFLD model of India. Lancet Gastroenterol Hepatol. 2023;8(11):969-970.
      Sarin SK, Prasad M, Ramalingam A, Kapil U. Integration of public health measures for NAFLD into India's national programme for NCDs. Lancet Gastroenterol Hepatol. 2021;6(10):777-778.
      Krag A, Buti M, Lazarus JV, Allen AM, Bowman J, Burra P, et al. Uniting to defeat steatotic liver disease: a global mission to promote healthy livers and healthy lives. J Hepatol. 2023;79(5):1076-1078.
      Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889-919.
    • Publication Date:
      Date Created: 20240311 Date Completed: 20240312 Latest Revision: 20240312
    • Publication Date:
      20240312
    • Accession Number:
      10.1111/apt.17921
    • Accession Number:
      38462700